REP. BLILEY LIKELY TO REPLACE DINGELL AS CONGRESSIONAL OVERLORD ON FDA ISSUES
This article was originally published in The Tan Sheet
Executive Summary
REP. BLILEY LIKELY TO REPLACE DINGELL AS CONGRESSIONAL OVERLORD ON FDA ISSUES in the Republican 104th Congress. As ranking minority member of the House Energy & Commerce/health subcommittee, Rep. Thomas Bliley (R-Va.) is next in line to become chairman of the subcommittee, and may jump ahead one place in seniority and be offered the top post on the full committee. Rep. Carlos Moorhead (R-Calif.) is the full committee's ranking Republican, but faces some opposition from within his party for ascension to the prestigious committee post previously held by Rep. John Dingell (D-Mich.) The health subcommittee has been the power base for Rep. Henry Waxman (D-Calif.) for 16 years.